MedTrace Logo

A Sub-Chronic Evaluation of the Safety of Celastrol in Human Subjects

NCT05494112 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2022-08-09

No results posted yet for this study

Summary

This is an open label safety study that will not be blinded or placebo controlled.

Purpose is to evaluate the safety of Celastrol in healthy men and women volunteers, between 18 and 40 years of age, over a 90-day period.

Celastrol is different than Cholesterol. Cholesterol is a risk for heart disease. Celastrol is a natural occurring compound extracted from the root of Tripterygium wilfordii, a herb used in Chinese medicine.

Conditions

  • Safety

Interventions

DIETARY_SUPPLEMENT

Celastrol

same dose of Celastrol will be given every day for a period of 90-days to all participants.

Sponsors & Collaborators

  • Legend Labz, Inc.

    lead INDUSTRY

Principal Investigators

  • Rubin Patel, MD · Patient Plus Urgent Care

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-25
Primary Completion
2023-05-25
Completion
2023-05-25

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05494112 on ClinicalTrials.gov